Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrasekaran Padmapriyadarsini

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Plos One|July 16, 2024
Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approachAmarendra Mahapatra, Kannan Thiruvengadam, Dina Nair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2011
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in IndiaChandrasekaran Padmapriyadarsini, S Ramesh Kumar, Norma Terrin, et al.
Therapeutic Drug Monitoring|June 9, 2023
Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults With Drug-Resistant Pulmonary TuberculosisShanmugam Murugaiha Jeyakumar, Namrata K Bhui, Neeta Singla, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 12, 2025
Characterisation of M. tuberculosis isolates obtained from Tamil Nadu prevalence survey by whole genome sequencing analysisPriya Rajendran, Prathiksha Giridaran, Silla Varghese Thomas, et al.
AIDS Research and Human Retroviruses|March 18, 2022
Molecular Characterization of the <i>pol</i> Gene of Vertically Transmitted HIV-1 Strains in Children with Virological FailureRamesh Karunaianantham, Manohar Nesa Kumar, Bindu Gopalan, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary TuberculosisChandrasekaran Padmapriyadarsini, Rajesh Solanki, S M Jeyakumar, et al.
BMJ Open|March 4, 2019
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trialChandrasekaran Padmapriyadarsini, Perumal K Bhavani, Mohan Natrajan, et al.
Tuberculosis (Edinburgh, Scotland)|February 19, 2022
Characterization of probes associated with rifampicin resistance in M.tuberculosis detected by GenXpert from a national reference laboratory at ChennaiPriya Rajendran, Michel Prem Kumar, Kannan Thiruvengadam, et al.
Microbiology Spectrum|May 18, 2026
Pilot evaluation of a compact targeted next-generation sequencing with minimum biocontainment for rapid diagnosis of drug-resistant tuberculosisRadha Gopalaswamy, Ashok Kumar Shanmugavel, Bhargavi Subramanian, et al.
Journal of Travel Medicine|July 28, 2022
Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concernNathella Pavan Kumar, V V Banurekha, C P Girish Kumar, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Plos One|July 16, 2024
Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approachAmarendra Mahapatra, Kannan Thiruvengadam, Dina Nair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2011
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in IndiaChandrasekaran Padmapriyadarsini, S Ramesh Kumar, Norma Terrin, et al.
Therapeutic Drug Monitoring|June 9, 2023
Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults With Drug-Resistant Pulmonary TuberculosisShanmugam Murugaiha Jeyakumar, Namrata K Bhui, Neeta Singla, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 12, 2025
Characterisation of M. tuberculosis isolates obtained from Tamil Nadu prevalence survey by whole genome sequencing analysisPriya Rajendran, Prathiksha Giridaran, Silla Varghese Thomas, et al.
AIDS Research and Human Retroviruses|March 18, 2022
Molecular Characterization of the <i>pol</i> Gene of Vertically Transmitted HIV-1 Strains in Children with Virological FailureRamesh Karunaianantham, Manohar Nesa Kumar, Bindu Gopalan, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary TuberculosisChandrasekaran Padmapriyadarsini, Rajesh Solanki, S M Jeyakumar, et al.
BMJ Open|March 4, 2019
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trialChandrasekaran Padmapriyadarsini, Perumal K Bhavani, Mohan Natrajan, et al.
Tuberculosis (Edinburgh, Scotland)|February 19, 2022
Characterization of probes associated with rifampicin resistance in M.tuberculosis detected by GenXpert from a national reference laboratory at ChennaiPriya Rajendran, Michel Prem Kumar, Kannan Thiruvengadam, et al.
Microbiology Spectrum|May 18, 2026
Pilot evaluation of a compact targeted next-generation sequencing with minimum biocontainment for rapid diagnosis of drug-resistant tuberculosisRadha Gopalaswamy, Ashok Kumar Shanmugavel, Bhargavi Subramanian, et al.
Journal of Travel Medicine|July 28, 2022
Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concernNathella Pavan Kumar, V V Banurekha, C P Girish Kumar, et al.
Pageof 8